The Evolving Landscape of GLP-1 Therapy in United States PharmaciesThe landscape of metabolic health in the United States has actually gone through a seismic shift over the last couple of years. At the center of this change is a class of medications known as Glucagon-Like Peptide-1 (GLP-1) receptor agonists. Initially
